Does Rallies show 13F holders for CSBR?

Yes. Rallies tracks hedge fund and 13F ownership data for CSBR, including fund names, share counts, latest tracked quarter, and position changes when available.

Is CSBR research on Rallies investment advice?

No. Rallies provides research, data, and educational context for CSBR. It does not provide personalized investment advice.

CSBR (Champions Oncology, Inc.) Stock Analysis - Hedge Fund Holdings

Champions Oncology, Inc. (CSBR) is a publicly traded Healthcare sector company. As of May 21, 2026, CSBR trades at $5.99 with a market cap of $84.29M and a P/E ratio of 17.65. CSBR moved +0.00% today. Year to date, CSBR is -9.16%; over the trailing twelve months it is +2.20%. Its 52-week range spans $3.75 to $11.99. Rallies surfaces CSBR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns CSBR stock?

Hedge funds tracked by Rallies that own CSBR include Renaissance Technologies and Citadel Advisors. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Champions Oncology, Inc..

CSBR Key Metrics

Key financial metrics for CSBR
Metric	Value
Price	$5.99
Market Cap	$84.29M
P/E Ratio	17.65
EPS	$0.34
Dividend Yield	0.00%
52-Week High	$11.99
52-Week Low	$3.75
Volume	0
Avg Volume	0
Revenue (TTM)	$56.94M
Net Income	$4.70M
Gross Margin	50.15%

Top Hedge Funds Holding CSBR

Renaissance Technologies holds 138.84K shares of CSBR, changed +15.71% as of Dec 31, 2024.
Citadel Advisors holds 10.87K shares of CSBR, changed +6.36% as of Dec 31, 2024.

Latest CSBR News

Champions Oncology Q3 Services Revenue Rises 32% to $16.6M, EBITDA Positive — Mar 19, 2026

Recent CSBR Insider Trades

Mendelson Daniel Newman bought 1.00K (~$6.50K) on Jan 12, 2024.
Mendelson Daniel Newman bought 2.00K (~$12.54K) on Jan 11, 2024.
Mendelson Daniel Newman bought 2.94K (~$18.58K) on Jan 10, 2024.

CSBR Analyst Consensus

CSBR analyst coverage data. Average price target: $0.00.

Common questions about CSBR

Who owns CSBR stock?: Hedge funds tracked by Rallies that own CSBR include Renaissance Technologies and Citadel Advisors. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Champions Oncology, Inc..
Does Rallies show 13F holders for CSBR?: Yes. Rallies tracks hedge fund and 13F ownership data for CSBR, including fund names, share counts, latest tracked quarter, and position changes when available.
Is CSBR research on Rallies investment advice?: No. Rallies provides research, data, and educational context for CSBR. It does not provide personalized investment advice.